Sequential ATR and PARP Inhibition Overcomes Acquired DNA Damaging Agent Resistance in Pancreatic Ductal Adenocarcinoma
Katharine J. Herbert, Rosanna Upstill‐Goddard, Stephan B. Dreyer…·David Kuang-Fu Chang
This study shows that sequential ATR and PARP inhibition can overcome acquired resistance to DNA damaging agents in pancreatic ductal adenocarcinoma.